These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 30109000)
21. A new class of anti-proliferative activity and apoptotic inducer with molecular docking studies for a novel of 1,3-dithiolo[4,5- Ismail MA; Abusaif MS; El-Gaby MSA; Ammar YA; Ragab A RSC Adv; 2023 Apr; 13(18):12589-12608. PubMed ID: 37101951 [TBL] [Abstract][Full Text] [Related]
23. Design, Synthesis, Antitumor Activity Evaluation, and Molecular Dynamics Simulation of Some 2-Aminopyrazine Derivatives. Cui H; Zhang R; Xiong X; Cui Z; Min Z; Liu J; Li X; Min Z Curr Comput Aided Drug Des; 2024 Mar; ():. PubMed ID: 38485684 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3). Madasu C; Karri S; Sangaraju R; Sistla R; Uppuluri MV Eur J Med Chem; 2020 Feb; 188():111974. PubMed ID: 31883489 [TBL] [Abstract][Full Text] [Related]
26. In-vitro Evaluation of Isatin Derivatives as Potent Anti-Breast Cancer Agents against MCF-7, MDA MB 231, MDA-MB 435 and MDA-MB 468 Breast Cancers Cell Lines: A Review. Chauhan G; Pathak DP; Ali F; Dubey P; Khasimbi S Anticancer Agents Med Chem; 2022; 22(10):1883-1896. PubMed ID: 34477529 [TBL] [Abstract][Full Text] [Related]
27. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition. Maher M; Kassab AE; Zaher AF; Mahmoud Z Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080 [TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of substituted dihydropyrimidinone derivatives as cytotoxic and tubulin polymerization inhibitors. Sana S; Tokala R; Bajaj DM; Nagesh N; Bokara KK; Kiranmai G; Lakshmi UJ; Vadlamani S; Talla V; Shankaraiah N Bioorg Chem; 2019 Dec; 93():103317. PubMed ID: 31586714 [TBL] [Abstract][Full Text] [Related]
30. 5-(4-Hydroxyphenyl)-3H-1,2-dithiole-3-thione derivatives of brefeldin A: Design, synthesis and cytotoxicity in MDA-MB-231 human breast cancer cells. Wang M; Sun B; Ye T; Wang Y; Hou Y; Wang S; Pan H; Hua H; Li D Bioorg Med Chem; 2023 Jul; 90():117380. PubMed ID: 37329677 [TBL] [Abstract][Full Text] [Related]
31. Computational Design, Synthesis, and Bioevaluation of 2-(Pyrimidin-4-yl)oxazole-4-carboxamide Derivatives: Dual Inhibition of EGFR Raghunath Khedkar N; Sindkhedkar M; Joseph A Bioorg Chem; 2024 Feb; 143():107027. PubMed ID: 38096682 [TBL] [Abstract][Full Text] [Related]
32. Design and synthesis of 4'-O-alkylamino-tethered-benzylideneindolin-2-ones as potent cytotoxic and apoptosis inducing agents. Senwar KR; Reddy TS; Thummuri D; Sharma P; Bharghava SK; Naidu VG; Shankaraiah N Bioorg Med Chem Lett; 2016 Aug; 26(16):4061-9. PubMed ID: 27397498 [TBL] [Abstract][Full Text] [Related]
33. Anti-breast cancer potential of frullanolide from Chimplee S; Graidist P; Srisawat T; Sukrong S; Bissanum R; Kanokwiroon K Oncol Lett; 2019 Jun; 17(6):5283-5291. PubMed ID: 31186745 [TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and molecular docking study of new pyrimidine-based hydrazones with selective anti-proliferative activity against MCF-7 and MDA-MB-231 human breast cancer cell lines. Badawi WA; Samir M; Fathy HM; Okda TM; Noureldin MH; Atwa GMK; AboulWafa OM Bioorg Chem; 2023 Sep; 138():106610. PubMed ID: 37210828 [TBL] [Abstract][Full Text] [Related]
35. A novel class of C14-sulfonate-tetrandrine derivatives as potential chemotherapeutic agents for hepatocellular carcinoma. Jiang T; Xie G; Zeng Z; Lan J; Liu H; Li J; Ren H; Chen T; Pan W Front Chem; 2022; 10():1107824. PubMed ID: 36704617 [TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and in vitro anticancer research of novel tetrandrine and fangchinoline derivatives. Gao XZ; Lv XT; Zhang RR; Luo Y; Wang MX; Chen JS; Zhang YK; Sun B; Sun JY; Liu YF; Liu C Bioorg Chem; 2021 Apr; 109():104694. PubMed ID: 33601141 [TBL] [Abstract][Full Text] [Related]
37. Selective Induction of DNA Damage and Cell Cycle Arrest Mediated by Chromone-Triazole Dyads Derivatives: Effects on Breast and Prostate Cancer Cells. Saher L; Monteiro FL; Rocha DHA; Albuquerque HMT; Silva AMS; Helguero LA Chem Biodivers; 2023 Jul; 20(7):e202300251. PubMed ID: 37387248 [TBL] [Abstract][Full Text] [Related]
38. Synthesis, in vitro Antiproliferative and Antiinflammatory Activities, and Kinase Inhibitory effects of New 1,3,4-triarylpyrazole Derivatives. El-Gamal MI; Abdel-Maksoud MS; Gamal El-Din MM; Shin JS; Lee KT; Yoo KH; Oh CH Anticancer Agents Med Chem; 2017; 17(1):75-84. PubMed ID: 27334850 [TBL] [Abstract][Full Text] [Related]
39. Anticancer effects of synthetic hexahydrobenzo [g]chromen-4-one derivatives on human breast cancer cell lines. Pordeli M; Nakhjiri M; Safavi M; Ardestani SK; Foroumadi A Breast Cancer; 2017 Mar; 24(2):299-311. PubMed ID: 27250840 [TBL] [Abstract][Full Text] [Related]
40. Selective Cytotoxic Effects of 5-Trifluoromethoxy-1H-indole-2,3-dione 3-Thiosemicarbazone Derivatives on Lymphoid-originated Cells. Danışman-Kalındemirtaş F; Erdem-Kuruca S; Akgün-Dar K; Karakaş Z; Soylu Ö; Karali N Anticancer Agents Med Chem; 2022; 22(2):349-355. PubMed ID: 33653255 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]